¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"molecular check point gene"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • dew point determination apparatus
    ³ëÁ¡°è
  • disparate point
    ºñ´ëÀÀÁ¡
  • exclamation point hair
    °¨ÅººÎÈ£ÅÐ
  • focal point
    ÃÊÁ¡
  • freezing point
    ¾î´ÂÁ¡, ºùÁ¡
  • freezing point depression
    ¾î´ÂÁ¡°­ÇÏ, ºùÁ¡°­ÇÏ
  • far point
    ¿øÁ¡
  • gingival point angle
    ÀÕ¸ö¸ð¼­¸®°¢
  • jugomaxillary point
    ±¤´ë¾Õ¾Æ·¡Á¡, Çù»ó¾ÇÁ¡
  • leaking point
    »ùÁ¡, ´©ÃâÁ¡
  • leak-point pressure
    ´©ÃâÁ¡¾Ð
  • lacrimal point
    ´«¹°Á¡
  • malar point
    ±¤´ëÁ¡
  • motor point
    ¿îµ¿Á¡
  • McBurney¡¯s point
    ¸Æ¹ö´ÏÁ¡
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • boiling point
    ²ú´ÂÁ¡, ºñµîÁ¡
  • cardinal point
    ±âº»Á¡
  • conjugate point
    ÄÓ·¹Á¡, °áÇÕÁ¡
  • corresponding point
    ´ëÀÀÁ¡
  • craniometric point
    µÎ°³°èÃøÁ¡, ¸Ó¸®°èÃøÁ¡
  • critical point
    ÀÓ°èÁ¡
  • cut-off point
    °áÁ¤Á¡
  • point charge
    Á¡ÇÏÀü
  • three point balancing contact
    »ïÁ¡Á¢Ã˱³ÇÕ
  • disparate point
    ºñ´ëÀÀÁ¡
  • freezing point depression
    ¾î´ÂÁ¡°­ÇÏ
  • point discharge
    Á¡¹æÀü
  • two point discrimination
    µÎÁ¡½Äº°
  • end-point nystagmus
    ±ØÀ§´«¶³¸², ±ØÀ§¾ÈÁø
  • exclamation point hair
    °¨ÅººÎÈ£ÅÐ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • immediate early gene
    Á¶±â ¹ßÇö À¯ÀüÀÚ
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ.
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
  • immunoglobulin (Ig) gene
    ¸é¿ª±Û·ÎºÒ¸° À¯ÀüÀÚ
  • immunoglobulin gene
    ¸é¿ª±Û·ÎºÒ¸°À¯ÀüÀÎÀÚ
  • ras gene
    ras À¯ÀüÀÚ(¡­ë¶îîí­)
  • rb gene
    Rb À¯ÀüÀÚ(¡­ë¶îîí­)
  • recessive autosomal gene
    ¿­¼ºº¸Åë¿°»öüÀ¯ÀüÀÚ
  • recessive gene
    ¿­¼ºÀ¯ÀüÀÚ(¡­ë¶îîí­).
  • recessive gene
    ¿­¼ºÀ¯ÀüÀÚ
  • recessive gonosomal gene
    ¿­¼º¼º¿°»öüÀ¯ÀüÀÚ
  • recombination, gene
    À¯ÀüÀÚÀçÁ¶ÇÕ
  • regulator gene
    Á¶ÀýÀ¯ÀüÀÚ(ðàï½ë¶îîí­).
  • J point
    J Á¡(ïÇ)
  • NPA->near point of accommodation
    Á¶Àý±ÙÁ¡
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • molecular extinction coefficient
    ºÐÀÚ¼Ò¸ê°è¼ö(¡­á¼ØþÌõâ¦).
  • molecular fat
    ºÐÀÚ¼º Áö¹æ(¡­àõò·Û¸).
  • molecular film
    ºÐÀÚ¸·(ÝÂí­Ø¯).
  • molecular filter
    ºÐÀڰŸ£°³.
  • molecular force
    ºÐÀÚ·Â(ÝÂí­æ³).
  • molecular form
    ºÐÀÚÇüÅÂ
  • molecular formula
    ºÐÀÚ½Ä(ÝÂí­ãÒ).
  • molecular genetic study
    ºÐÀÚÀ¯ÀüÇÐ<ÀÚ>°Ë»ç
  • molecular genetics
    ºÐÀÚÀ¯ÀüÇÐ(¡­ë¶îîùÊ).
  • molecular genetics
    ºÐÀÚÀ¯ÀüÇÐ
  • molecular grating
    ºÐÀÚ°ÝÀÚ(ÝÂí­Ì«í­).
  • molecular heat
    ºÐÀÚ¿­(ÝÂí­æð).
  • molecular hypothesis
    ºÐÀÚ°¡¼³.
  • molecular layer
    ºÐÀÚÃþ(ÝÂí­öµ).
  • molecular layer
    ºÐÀÚÃþ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • growing point
    ¼ºÀåÁ¡(à÷íþïÇ)
  • hinge point
    µ¹Â¼±Í Á¡(ïÃ)
  • initiation point
    °³½ÃÁ¡(ËÒã·ïÇ)
  • isoelectric point
    µîÀüÁ¡(Ôõï³ïÇ)
  • isoelectrophoretic point
    µîÀü Àü±â¿µµ¿Á¡(Ôõï³ï³Ñ¨ç¶ÔÑïÇ)
  • isoionic point
    µî(Ôõ)À̿ Á¡(ïÇ)
  • isoprotic point
    µî¾çÀÚ Á¡(ÔõåÕí­ïÇ)
  • isosbestic point
    µîÈí±¤Á¡(ÔõýåÎÃïÇ)
  • light compensation point
    ±¤ º¸»óÁ¡(ÎÃÜÍßÁïÃ)
  • melting point
    À¶ÇØÁ¡(ë×ú°ïÆ)
  • point mutation
    Á¡º¯ÀÌ(ïÃܨì¶)
  • point quenching
    Á¡¼ÒÆÎ(ïÃá¼ÎÃ)
  • point symmetry
    Á¡´ëĪ(ïÃÓßöà)
  • restriction point
    Á¦ÇÑÁ¡(ð¤ùÚïÃ)
  • R point
    (å²) Restriction point
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
HCT health check test; hematocrit; historic control trial; homocytotrophic; human calcitonin; hydrochlor...
HSCL Hopkins Symptom Check List
MAACL Multiple Affect Adjective Check List
NC nasal cannula; nasal clearance; neck complaint; neonatal cholestasis; neural crest; neurologic check...
PDCA plan-do-check-act
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CPD Critical point drying
GPA Grade Point Average
HACCP Hazard Analysis Critical Control Point
HACCP Hazard Analysis and Critical Control Point
LPP Leak point pressure
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • molecular force
    ºÐÀÚ·Â
  • molecular formula
    ºÐÀÚ½Ä
  • molecular genetics
    ºÐÀÚ À¯ÀüÇÐ
  • molecular heat
    ºÐÀÚ ¿­
  • molecular layer
    ºÐÀÚ Ãþ
  • molecular magnet
    ºÐÀÚ ÀÚ¼®
  • molecular miocrobiology
    ºÐÀÚ ¹Ì»ý¹°ÇÐ
  • molecular orientation
    ºÐÀÚ ¹èÇâ
  • molecular physiology
    ºÐÀÚ »ý¸®ÇÐ
  • molecular rearrangement
    ºÐÀÚ Àç¹è¿­
  • molecular shape
    ºÐÀÚ Çü»ó
  • molecular site
    ºÐÀÚ À§
  • molecular still
    ºÐÀÚ Áõ·ù±â
  • molecular tension
    ºÐÀÚ Àå·Â
  • molecular tumbling
    ºÐÀÚ ÅÒºí¸µ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
evolution, molecular Evolution at the molecular level of DNA sequences and proteins. (rieger et al., glossary of genetics: classical and molecular, 5th ed)
(12 Dec 1998)
kinetic molecular theory <chemistry> This theory assumes that molecules must collide in order to react. The more collisions the more likely it is for a reaction to occur.
However, depending on the conditions, only a small fraction of the collisions are effective in producing a reaction. There are several constraints. In order for a reaction to occur, bonds initially are broken, which requires energy. This energy depends on the type of the reaction and comes from the kinetic energies that the molecules possess before the collision. It is called the activation energy. Increasing the temperature increases the kinetic energies and more collisions will occur. In adition, at a higher temperature a greater number of the reacting molecules might possess an energy equal to or greater than the activation energy. However the molecules must also collide in a specific orientation, called the steric factor in order for a reaction to occur.
A reaction will only be successful, if the collision has enough energy to be either equal to or greater than the activation energy and if the orientation of the collision allows for correct bond formation. These factors are in the Arrhenius equation: k = zp The rate constant k is proportional to the Arrhenius factor A. A is the product of the collision frequency z, and the steric factor p. The fraction of collisions with sufficient energy to produce a reaction are in the term of the equation.
(09 Jan 1998)
kininogen, high-molecular-weight A plasma protein, molecular weight of 110 kD, that normally exists in plasma in a 1:1 complex with prekallikrein. Hmwk is split by plasma kallikrein to produce bradykinin. The complex is a cofactor in the activation of coagulation factor xii. The product of this reaction, xiia, in turn activates prekallikrein to kallikrein.
(12 Dec 1998)
kininogen, low-molecular-weight A protein, molecular weight 50 kD, located in various normal tissues. Upon cleavage by kallikrein or other kallikreins, it forms kallidin. Kallidin, in turn, is converted into bradykinin.
(12 Dec 1998)
alveolar point The most anterior point on the maxillary alveolar process in the midline.
Synonym: alveolar point, prostheon.
Origin: G. Ntr. Of prosthios, foremost
(05 Mar 2000)
anterior focal point The point where parallel rays from the retina are focused.
(05 Mar 2000)
apophysial point The centre of the root of the anterior nasal spine.
Synonym: apophysary point, apophysial point, spinal point.
(05 Mar 2000)
arrow point tracing A tracing of mandibular movements made by means of a device attached to the opposing arches; its shape resembles that of an arrowhead or a Gothic arch, and when the instrument's marking point is at the apex of the arch, the jaws are considered to be in centric relation.
Synonym: arrow point tracing, Gothic arch tracing, Gothic arch, stylus tracing.
(05 Mar 2000)
auricular point A craniometric point at the centre of the opening of the external acoustic meatus; or, in certain cases, the middle of the upper edge of this opening.
Synonym: auricular point.
Origin: L. Auricularis, pertaining to the ear
(05 Mar 2000)
axial point One of two point's in a compound optical system so related that a ray directed toward the first point will appear to have passed through the second point parallel to its original direction.
Synonym: axial point.
(05 Mar 2000)
boiling point This is the temperature at which the vapor pressure of a given liquid reaches atmospheric pressure (and thus starts to boil).
(09 Oct 1997)
boiling point elevation This is the phenomenon of increasing the temperature at which a liquid boils by dissolving another substance in the liquid (for example: you can raise the temperature at which water boils by adding salt to it).
(09 Oct 1997)
Cannon's point The location in the mid-transverse colon at which innervation by superior and inferior mesenteric plexuses overlap at the junction of the primitive midgut and hindgut, frequently resulting in narrowing evident on barium enema.
See: Cannon's ring.
Synonym: Cannon's ring.
(05 Mar 2000)
painful point See: Valleix's points.
(05 Mar 2000)
malar point Apex of the tuberosity of the zygomatic (malar) bone.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • check-taker
    (±ØÀå µîÀÇ)ÁýÇ¥¿ø
  • claim check
    (¿Ê.ÁÖÂ÷ µîÀÇ)¹øÈ£Ç¥;¿¹Ä¡Ç¥;º¸°üÁõ;ÀÎȯ±Ç
  • cross-check
    (¿©·¯ ÀڷḦ)ºñ±³ °ËÅäÇÏ´Ù;´Ù¸¥ °¢µµ¿¡¼­ °ËÁõÇÏ´Ù;Å©·Î½ºÃ¼Å©ÇÏ´Ù;Á¤È®µµ °ËÅä;Å©·Î½ºÃ¼Å©
  • diviednd check
    (¿µ)¹è´ç ¼öÇ¥;¹è´ç±Ç
  • door check
    µµ¾îüũ(¹®ÀÌ ÃµÃµÈ÷ ´ÝÈ÷°Ô ÇÏ´Â ÀåÄ¡)
  • dope check
    (¼±¼öÀÇ)ÈïºÐÁ¦(¾à¹°)°Ë»ç
  • glen check
    =GLEN PLAID
  • oddeven check
    ÄÄÇ»ÅÍ ±â¿ì Á¶»ç
  • parity check
    ¦¼ö Ȧ¼ö °Ë»ç;ÆÐ¸®Æ¼ °Ë»ç(ÄÄÇ»ÅÍ Á¶ÀÛÀÇ À߸ø ¹ß°ß ¹æ¹ý)
  • pass check
    ÀÔÀå±Ç;ÀçÀÔÀå±Ç
  • perpetual check
    ¿µ±¸ À屺¼ö 
  • rain check
    ¿ìõ ±³È¯±Ç(ºñ·Î ¿Á¿Ü °æ±â°¡ ÁßÁöµÉ ¶§ °ü¶÷°´¿¡°Ô ÁÖ´Â ´ÙÀ½ ȸÀÇ À¯È¿Ç¥);(»óǰÀÇ Àç°í µîÀÌ ¾ø´Â °æ¿ì)ÈÄÀÏ ¿ì¼±ÀûÀ¸·Î ¹°Ç°(¼­ºñ½º)À» Á¦°øÇÑ´Ù´Â º¸Áõ±Ç;(Áö±ÝÀº »ç¾çÇÏÁö¸¸ ³ªÁß¿¡ ¿ä±¸ÇÒ)ÈÄÀÏÀÇ ¾à¼Ó(ÃÊ´ë.¿ä±¸)
  • redundancy check
    ¿©À¯µµ °Ë»ç(¿©ºÐÀÇ ºñÆ®¸¦ ºÎ°¡ÇÏ¿© À߸øÀ» °ËÃâÇϱâ)
  • rubber check
    ºÎµµ¼öÇ¥
  • spot check
    ¹«ÀÛÀ§(ÀÓÀÇ) °ßº» ÃßÃâ;ºÒ½Ã Á¡°Ë
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á